Cargando…

Association of sclerostin with cardiovascular events and mortality in dialysis patients

INTRODUCTION: Sclerostin has been reported to be a novel biomarker associated with the bone-vascular axis. In this study, we determined the relationships between serum sclerostin and all-cause mortality, the prevalence of cardiovascular events (CVEs), and coronary artery calcifications (CACs) in dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Yun, Yang, Min, Wang, Jiao, Cui, Li, Jiang, Zhenxing, Ding, Jiule, Li, Min, Zhou, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170300/ https://www.ncbi.nlm.nih.gov/pubmed/32216514 http://dx.doi.org/10.1080/0886022X.2020.1741386

Ejemplares similares

The systemic inflammation indexes predict all-cause mortality in peritoneal dialysis patients
por: Yang, Yan, et al.
Publicado: (2023)

Proton pump inhibitor usage is associated with higher all-cause mortality and CV events in peritoneal dialysis patients
por: Zeng, Yingsi, et al.
Publicado: (2022)

A nomogram predicts cardiovascular events in patients with peritoneal dialysis-associated peritonitis
por: Huang, Dan-dan, et al.
Publicado: (2022)

Serum sclerostin in vascular calcification in CKD: a meta-analysis
por: Lin, Yan, et al.
Publicado: (2023)

Assessment of complications and short-term outcomes of percutaneous peritoneal dialysis catheter insertion by conventional or modified Seldinger technique
por: Zou, Yun, et al.
Publicado: (2021)

Personality traits and peritoneal dialysis patients’ prognosis
por: Chen, Tianlei, et al.
Publicado: (2023)

The relationship between platelet distribution width and new-onset cardiovascular disease events in patients with peritoneal dialysis
por: Su, Ning, et al.
Publicado: (2022)

Circulating levels of sclerostin are associated with cardiovascular mortality
por: Novo-Rodríguez, Cristina, et al.
Publicado: (2018)

Mean platelet volume may predict all-cause and cardiovascular mortality among incident peritoneal dialysis patients
por: Jiang, Wenyu, et al.
Publicado: (2023)

Risk factors and outcomes of cardiovascular disease readmission within the first year after dialysis in peritoneal dialysis patients
por: Li, Jianbo, et al.
Publicado: (2021)

Sclerostin and Cardiovascular Disease
por: Tobias, Jonathan H.
Publicado: (2023)

What is the relationship between sclerostin and cardiovascular events in hemodialysis patients?
por: Zhao, Yu, et al.
Publicado: (2020)

Relationship between serum bilirubin levels and mortality in patients on peritoneal dialysis
por: Zhan, Xiaojiang, et al.
Publicado: (2019)

Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis
por: Liu, Siyi, et al.
Publicado: (2020)

Elevated serum fatty acid-binding protein 4 level predicts all-cause and cardiovascular mortality in peritoneal dialysis patients: a five-year study
por: Zhou, Sijia, et al.
Publicado: (2023)

Platelet-to-albumin ratio: a risk factor associated with technique failure and mortality in peritoneal dialysis patients
por: Yang, Yuqi, et al.
Publicado: (2021)

Radial augmentation index may be an effective predictor of vascular calcification in patients on peritoneal dialysis
por: Yang, Ning, et al.
Publicado: (2020)

A Study to Inform the Design of a National Multicentre Randomised Controlled Trial to Evaluate If Reducing Serum Phosphate to Normal Levels Improves Clinical Outcomes including Mortality, Cardiovascular Events, Bone Pain, or Fracture in Patients on Dialysis
por: Bhargava, Ramya, et al.
Publicado: (2015)

Cystatin C as a Predictor of Mortality and Cardiovascular Events in a Population with Chronic Kidney Disease
por: Vigil, Ana, et al.
Publicado: (2014)

Risk factors for mortality in patients undergoing peritoneal dialysis: a systematic review and meta-analysis
por: Zhang, Jialing, et al.
Publicado: (2021)

The Correlation between Serum Sclerostin Level and Arterial Stiffness in Peritoneal Dialysis Patients
por: Liu, Fang, et al.
Publicado: (2022)

Early-start and conventional-start peritoneal dialysis: a Chinese cohort study on outcome
por: Wang, Ying, et al.
Publicado: (2020)

Comparison of clinical outcome between incremental peritoneal dialysis and conventional peritoneal dialysis: a propensity score matching study
por: Lee, Su Mi, et al.
Publicado: (2021)

Hydroxychloroquine- and chloroquine-related cardiovascular events
Publicado: (2020)

Serum alkaline phosphatase levels correlate with long-term mortality solely in peritoneal dialysis patients with residual renal function
por: Zhan, Xiaojiang, et al.
Publicado: (2019)

Association of trimethylamine N-Oxide with cardiovascular and all-cause mortality in hemodialysis patients
por: Zhang, Pan, et al.
Publicado: (2020)

Apo A1/Apo B ratio and acute coronary syndrome among peritoneal dialysis patients
por: Chen, Tianlei, et al.
Publicado: (2021)

Peritoneal Protein Clearance Is Associated With Cardiovascular Events but Not Mortality in Peritoneal Dialysis Patients
por: Niu, Wei, et al.
Publicado: (2022)

Use of the systemic inflammation response index (SIRI) as a novel prognostic marker for patients on peritoneal dialysis
por: Li, Jiaqi, et al.
Publicado: (2022)

Association of short-term blood pressure variability with cardiovascular mortality among incident hemodialysis patients
por: Feng, Yiduo, et al.
Publicado: (2018)

Exploring the Role of Sclerostin as a Biomarker of Cardiovascular Disease and Mortality: A Scoping Review
por: Sanabria-de la Torre, Raquel, et al.
Publicado: (2022)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

Associations of Serum Dickkopf‐1 and Sclerostin With Cardiovascular Events: Results From the Prospective Bruneck Study
por: Klingenschmid, Gerhard, et al.
Publicado: (2020)

Impact of acute kidney injury on the risk of mortality in patients with cirrhosis: a systematic review and meta-analysis
por: Ning, Yunfeng, et al.
Publicado: (2022)

Effect of national holidays on health outcomes of patients receiving peritoneal dialysis in a single center over a ten-year period
por: Yang, Wei, et al.
Publicado: (2023)

Changes in the glymphatic system before and after dialysis initiation in patients with end-stage kidney disease
por: Lee, Yoo Jin, et al.
Publicado: (2023)

Sclerostin regulation: a promising therapy for periodontitis by modulating alveolar bone
por: Li, Tian-Jiao, et al.
Publicado: (2020)

Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT)
por: Levin, Adeera, et al.
Publicado: (2013)

Prevalence of coronary artery calcification and its association with mortality, cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis
por: Wang, Xue-Rong, et al.
Publicado: (2019)

Effect of different dialysis duration on the prognosis of peritoneal dialysis-associated peritonitis: a single-center, retrospective study
por: Liang, Qichen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kt2mk0t1a0iipmu76flj1rr5d2